Scientists Discover an Unexpected Mental Health Benefit of Ozempic

Ozempic, a drug used to treat type 2 diabetes, has been found to have an unexpected mental health benefit. This discovery follows a systematic review of psychiatric safety and antidepressant potential of GLP-1 receptor agonists. The review, published in Cureus, suggests that these drugs may have positive effects on mental health. The discovery comes amid rising prescriptions of GLP-1 drugs among adults with serious mental illness.

MedPage Today notes that scripts for these drugs are increasing faster in this population than in the general public. However, not all coverage is positive. A psychiatrist quoted in vocfm.co.za warns of potential mental health risks linked to GLP-1 weight-loss drugs. The Mossel Bay Advertiser also discusses the need for users of Ozempic, Wegovy, and Mounjaro to be aware of mental health implications.

The exact nature of the mental health benefit and its mechanisms are not yet clear. The systematic review in Cureus does not specify the extent or consistency of the antidepressant potential. Additionally, the risks and benefits for different populations, including those with serious mental illness, are not fully understood. The balance of risks and benefits for these drugs in mental health treatment is still an open question.